The	O
Diabetes	B:C0015194
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
:	O
Construct	O
and	O
Content	O
Validation	O
Using	O
a	O
Modified	O
Delphi	I:C0011216
Method	I:C0011216
.	O

The	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	B:C0015194
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
:	O
Construct	O
and	O
Content	O
Validation	O
Using	O
a	O
Modified	O
Delphi	I:C0011216
Method	I:C0011216
.	O

The	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
:	O
Construct	B:C2827421
and	O
Content	O
Validation	O
Using	O
a	O
Modified	O
Delphi	I:C0011216
Method	I:C0011216
.	O

The	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
:	O
Construct	O
and	O
Content	O
Validation	B:C1519941
Using	O
a	O
Modified	O
Delphi	I:C0011216
Method	I:C0011216
.	O

The	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
:	O
Construct	O
and	O
Content	O
Validation	O
Using	O
a	O
Modified	B:C0011216
Delphi	I:C0011216
Method	I:C0011216
.	O

In	O
order	O
to	O
scale	O
-	O
up	O
successful	O
innovations	O
,	O
more	O
evidence	O
is	O
needed	O
to	O
evaluate	B:C0220825
programs	O
that	O
attempt	O
to	O
address	O
the	O
rising	O
prevalence	O
of	O
diabetes	O
and	O
the	O
associated	O
burdens	O
on	O
patients	O
and	O
the	O
healthcare	O
system	I:C0018696
.	O

In	O
order	O
to	O
scale	O
-	O
up	O
successful	O
innovations	O
,	O
more	O
evidence	O
is	O
needed	O
to	O
evaluate	O
programs	B:C0376691
that	O
attempt	O
to	O
address	O
the	O
rising	O
prevalence	O
of	O
diabetes	O
and	O
the	O
associated	O
burdens	O
on	O
patients	O
and	O
the	O
healthcare	O
system	I:C0018696
.	O

In	O
order	O
to	O
scale	O
-	O
up	O
successful	O
innovations	O
,	O
more	O
evidence	O
is	O
needed	O
to	O
evaluate	O
programs	O
that	O
attempt	O
to	O
address	O
the	O
rising	O
prevalence	O
of	O
diabetes	B:C0011847
and	O
the	O
associated	O
burdens	O
on	O
patients	O
and	O
the	O
healthcare	O
system	I:C0018696
.	O

In	O
order	O
to	O
scale	O
-	O
up	O
successful	O
innovations	O
,	O
more	O
evidence	O
is	O
needed	O
to	O
evaluate	O
programs	O
that	O
attempt	O
to	O
address	O
the	O
rising	O
prevalence	O
of	O
diabetes	O
and	O
the	O
associated	O
burdens	O
on	O
patients	O
and	O
the	O
healthcare	B:C0018696
system	I:C0018696
.	O

This	O
study	B:C2603343
aimed	O
to	O
assess	O
the	O
construct	O
and	O
content	O
validity	O
of	O
the	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
,	O
a	O
tool	O
developed	O
to	O
guide	O
the	O
evaluation	O
,	O
design	O
and	O
implementation	O
with	O
built	O
-	I:C0376554
in	I:C0376554
knowledge	I:C0376554
translation	O
principles	O
.	O

This	O
study	O
aimed	O
to	O
assess	O
the	O
construct	B:C2827421
and	O
content	O
validity	O
of	O
the	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
,	O
a	O
tool	O
developed	O
to	O
guide	O
the	O
evaluation	O
,	O
design	O
and	O
implementation	O
with	O
built	O
-	I:C0376554
in	I:C0376554
knowledge	I:C0376554
translation	O
principles	O
.	O

This	O
study	O
aimed	O
to	O
assess	O
the	O
construct	O
and	O
content	O
validity	O
of	O
the	O
Diabetes	B:C0015194
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
,	O
a	O
tool	O
developed	O
to	O
guide	O
the	O
evaluation	O
,	O
design	O
and	O
implementation	O
with	O
built	O
-	I:C0376554
in	I:C0376554
knowledge	I:C0376554
translation	O
principles	O
.	O

This	O
study	O
aimed	O
to	O
assess	O
the	O
construct	O
and	O
content	O
validity	O
of	O
the	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	B:C0015194
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
,	O
a	O
tool	O
developed	O
to	O
guide	O
the	O
evaluation	O
,	O
design	O
and	O
implementation	O
with	O
built	O
-	I:C0376554
in	I:C0376554
knowledge	I:C0376554
translation	O
principles	O
.	O

This	O
study	O
aimed	O
to	O
assess	O
the	O
construct	O
and	O
content	O
validity	O
of	O
the	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
,	O
a	O
tool	B:C0025663
developed	O
to	O
guide	O
the	O
evaluation	O
,	O
design	O
and	O
implementation	O
with	O
built	O
-	I:C0376554
in	I:C0376554
knowledge	I:C0376554
translation	O
principles	O
.	O

This	O
study	O
aimed	O
to	O
assess	O
the	O
construct	O
and	O
content	O
validity	O
of	O
the	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
,	O
a	O
tool	O
developed	O
to	O
guide	B:C2825826
the	O
evaluation	O
,	O
design	O
and	O
implementation	O
with	O
built	O
-	I:C0376554
in	I:C0376554
knowledge	I:C0376554
translation	O
principles	O
.	O

This	O
study	O
aimed	O
to	O
assess	O
the	O
construct	O
and	O
content	O
validity	O
of	O
the	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
,	O
a	O
tool	O
developed	O
to	O
guide	O
the	O
evaluation	B:C0220825
,	O
design	O
and	O
implementation	O
with	O
built	O
-	I:C0376554
in	I:C0376554
knowledge	I:C0376554
translation	O
principles	O
.	O

This	O
study	O
aimed	O
to	O
assess	O
the	O
construct	O
and	O
content	O
validity	O
of	O
the	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
(	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
)	O
,	O
a	O
tool	O
developed	O
to	O
guide	O
the	O
evaluation	O
,	O
design	O
and	O
implementation	O
with	O
built	B:C0376554
-	I:C0376554
in	I:C0376554
knowledge	I:C0376554
translation	O
principles	O
.	O

A	O
modified	B:C0011216
Delphi	I:C0011216
method	I:C0011216
,	O
including	O
3	O
individual	O
rounds	O
(	O
questionnaire	O
with	O
7	O
-	O
point	O
agreement	O
/	O
importance	O
Likert	I:C4087094
scales	I:C4087094
and	O
/	O
or	O
open	O
-	O
ended	O
questions	O
)	O
and	O
1	O
group	O
round	O
(	O
open	O
discussion	O
)	O
were	O
conducted	O
.	O

A	O
modified	O
Delphi	I:C0011216
method	I:C0011216
,	O
including	O
3	O
individual	O
rounds	O
(	O
questionnaire	B:C0034394
with	O
7	O
-	O
point	O
agreement	O
/	O
importance	O
Likert	I:C4087094
scales	I:C4087094
and	O
/	O
or	O
open	O
-	O
ended	O
questions	O
)	O
and	O
1	O
group	O
round	O
(	O
open	O
discussion	O
)	O
were	O
conducted	O
.	O

A	O
modified	O
Delphi	I:C0011216
method	I:C0011216
,	O
including	O
3	O
individual	O
rounds	O
(	O
questionnaire	O
with	O
7	O
-	O
point	O
agreement	O
/	O
importance	B:C4087094
Likert	I:C4087094
scales	I:C4087094
and	O
/	O
or	O
open	O
-	O
ended	O
questions	O
)	O
and	O
1	O
group	O
round	O
(	O
open	O
discussion	O
)	O
were	O
conducted	O
.	O

Twelve	O
experts	B:C0009817
in	O
diabetes	O
,	O
research	O
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	O
and	O
policy	O
from	O
Canada	O
(	O
Ontario	O
,	O
Quebec	O
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	B:C0011847
,	O
research	O
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	O
and	O
policy	O
from	O
Canada	O
(	O
Ontario	O
,	O
Quebec	O
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	O
,	O
research	B:C0035168
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	O
and	O
policy	O
from	O
Canada	O
(	O
Ontario	O
,	O
Quebec	O
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	O
,	O
research	O
,	O
knowledge	B:C3494164
translation	I:C3494164
,	O
evaluation	O
and	O
policy	O
from	O
Canada	O
(	O
Ontario	O
,	O
Quebec	O
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	O
,	O
research	O
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	B:C0220825
and	O
policy	O
from	O
Canada	O
(	O
Ontario	O
,	O
Quebec	O
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	O
,	O
research	O
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	O
and	O
policy	B:C0242456
from	O
Canada	O
(	O
Ontario	O
,	O
Quebec	O
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	O
,	O
research	O
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	O
and	O
policy	O
from	O
Canada	B:C0006823
(	O
Ontario	O
,	O
Quebec	O
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	O
,	O
research	O
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	O
and	O
policy	O
from	O
Canada	O
(	O
Ontario	B:C0029040
,	O
Quebec	O
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	O
,	O
research	O
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	O
and	O
policy	O
from	O
Canada	O
(	O
Ontario	O
,	O
Quebec	B:C0034390
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	O
,	O
research	O
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	O
and	O
policy	O
from	O
Canada	O
(	O
Ontario	O
,	O
Quebec	O
and	O
British	B:C0006193
Columbia	I:C0006193
)	O
and	O
Australia	O
participated	O
.	O

Twelve	O
experts	O
in	O
diabetes	O
,	O
research	O
,	O
knowledge	O
translation	I:C3494164
,	O
evaluation	O
and	O
policy	O
from	O
Canada	O
(	O
Ontario	O
,	O
Quebec	O
and	O
British	O
Columbia	I:C0006193
)	O
and	O
Australia	B:C0004340
participated	O
.	O

Qualitative	O
data	O
were	O
analyzed	B:C0039778
thematically	I:C0039778
and	O
confirmed	O
by	O
participants	O
.	O

Qualitative	O
data	O
were	O
analyzed	O
thematically	I:C0039778
and	O
confirmed	O
by	O
participants	B:C0679646
.	O

An	O
importance	B:C4087094
scale	I:C4087094
was	O
used	O
to	O
determine	O
a	O
priority	O
multi-level	O
indicator	I:C0282574
set	I:C0282574
.	O

An	O
importance	O
scale	I:C4087094
was	O
used	O
to	O
determine	O
a	O
priority	O
multi-level	B:C0282574
indicator	I:C0282574
set	I:C0282574
.	O

Items	O
rated	O
very	O
or	O
extremely	O
important	O
by	O
80	O
%	O
or	O
more	O
of	O
the	O
experts	B:C0009817
were	O
reviewed	O
in	O
the	O
final	O
group	O
round	O
to	O
build	O
the	O
final	O
set	O
.	O

Items	O
rated	O
very	O
or	O
extremely	O
important	O
by	O
80	O
%	O
or	O
more	O
of	O
the	O
experts	O
were	O
reviewed	O
in	O
the	O
final	O
group	O
round	O
to	O
build	O
the	O
final	O
set	B:C0282574
.	O

Participants	B:C0679646
reached	O
consensus	O
on	O
the	O
content	O
and	O
construct	O
validity	O
of	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
,	O
including	O
its	O
title	O
,	O
overall	O
goal	I:C0018017
,	O
5	O
-	O
step	O
evaluation	O
approach	I:C0220825
,	O
medical	O
and	O
nonmedical	O
determinants	O
of	I:C3658315
health	I:C3658315
schematics	I:C3658315
,	O
full	O
list	O
of	O
indicators	O
and	O
associated	O
measurement	O
tools	O
,	O
priority	O
multi-	O
level	I:C0282574
indicator	I:C0282574
set	I:C0282574
and	O
next	O
steps	O
in	O
DEFINE	O
's	I:C0015194
development	O
.	O

Participants	O
reached	O
consensus	O
on	O
the	O
content	O
and	O
construct	O
validity	O
of	O
Diabetes	B:C0015194
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
,	O
including	O
its	O
title	O
,	O
overall	O
goal	I:C0018017
,	O
5	O
-	O
step	O
evaluation	O
approach	I:C0220825
,	O
medical	O
and	O
nonmedical	O
determinants	O
of	I:C3658315
health	I:C3658315
schematics	I:C3658315
,	O
full	O
list	O
of	O
indicators	O
and	O
associated	O
measurement	O
tools	O
,	O
priority	O
multi-	O
level	I:C0282574
indicator	I:C0282574
set	I:C0282574
and	O
next	O
steps	O
in	O
DEFINE	O
's	I:C0015194
development	O
.	O

Participants	O
reached	O
consensus	O
on	O
the	O
content	O
and	O
construct	O
validity	O
of	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
,	O
including	O
its	O
title	O
,	O
overall	B:C0018017
goal	I:C0018017
,	O
5	O
-	O
step	O
evaluation	O
approach	I:C0220825
,	O
medical	O
and	O
nonmedical	O
determinants	O
of	I:C3658315
health	I:C3658315
schematics	I:C3658315
,	O
full	O
list	O
of	O
indicators	O
and	O
associated	O
measurement	O
tools	O
,	O
priority	O
multi-	O
level	I:C0282574
indicator	I:C0282574
set	I:C0282574
and	O
next	O
steps	O
in	O
DEFINE	O
's	I:C0015194
development	O
.	O

Participants	O
reached	O
consensus	O
on	O
the	O
content	O
and	O
construct	O
validity	O
of	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
,	O
including	O
its	O
title	O
,	O
overall	O
goal	I:C0018017
,	O
5	O
-	O
step	O
evaluation	B:C0220825
approach	I:C0220825
,	O
medical	O
and	O
nonmedical	O
determinants	O
of	I:C3658315
health	I:C3658315
schematics	I:C3658315
,	O
full	O
list	O
of	O
indicators	O
and	O
associated	O
measurement	O
tools	O
,	O
priority	O
multi-	O
level	I:C0282574
indicator	I:C0282574
set	I:C0282574
and	O
next	O
steps	O
in	O
DEFINE	O
's	I:C0015194
development	O
.	O

Participants	O
reached	O
consensus	O
on	O
the	O
content	O
and	O
construct	O
validity	O
of	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
,	O
including	O
its	O
title	O
,	O
overall	O
goal	I:C0018017
,	O
5	O
-	O
step	O
evaluation	O
approach	I:C0220825
,	O
medical	O
and	O
nonmedical	O
determinants	B:C3658315
of	I:C3658315
health	I:C3658315
schematics	I:C3658315
,	O
full	O
list	O
of	O
indicators	O
and	O
associated	O
measurement	O
tools	O
,	O
priority	O
multi-	O
level	I:C0282574
indicator	I:C0282574
set	I:C0282574
and	O
next	O
steps	O
in	O
DEFINE	O
's	I:C0015194
development	O
.	O

Participants	O
reached	O
consensus	O
on	O
the	O
content	O
and	O
construct	O
validity	O
of	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
,	O
including	O
its	O
title	O
,	O
overall	O
goal	I:C0018017
,	O
5	O
-	O
step	O
evaluation	O
approach	I:C0220825
,	O
medical	O
and	O
nonmedical	O
determinants	O
of	I:C3658315
health	I:C3658315
schematics	I:C3658315
,	O
full	O
list	O
of	O
indicators	O
and	O
associated	O
measurement	O
tools	B:C0025663
,	O
priority	O
multi-	O
level	I:C0282574
indicator	I:C0282574
set	I:C0282574
and	O
next	O
steps	O
in	O
DEFINE	O
's	I:C0015194
development	O
.	O

Participants	O
reached	O
consensus	O
on	O
the	O
content	O
and	O
construct	O
validity	O
of	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
,	O
including	O
its	O
title	O
,	O
overall	O
goal	I:C0018017
,	O
5	O
-	O
step	O
evaluation	O
approach	I:C0220825
,	O
medical	O
and	O
nonmedical	O
determinants	O
of	I:C3658315
health	I:C3658315
schematics	I:C3658315
,	O
full	O
list	O
of	O
indicators	O
and	O
associated	O
measurement	O
tools	O
,	O
priority	O
multi-	B:C0282574
level	I:C0282574
indicator	I:C0282574
set	I:C0282574
and	O
next	O
steps	O
in	O
DEFINE	O
's	I:C0015194
development	O
.	O

Participants	O
reached	O
consensus	O
on	O
the	O
content	O
and	O
construct	O
validity	O
of	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
,	O
including	O
its	O
title	O
,	O
overall	O
goal	I:C0018017
,	O
5	O
-	O
step	O
evaluation	O
approach	I:C0220825
,	O
medical	O
and	O
nonmedical	O
determinants	O
of	I:C3658315
health	I:C3658315
schematics	I:C3658315
,	O
full	O
list	O
of	O
indicators	O
and	O
associated	O
measurement	O
tools	O
,	O
priority	O
multi-	O
level	I:C0282574
indicator	I:C0282574
set	I:C0282574
and	O
next	O
steps	O
in	O
DEFINE	B:C0015194
's	I:C0015194
development	O
.	O

Validated	B:C1519941
by	O
experts	O
,	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
has	O
the	O
right	O
theoretic	O
components	O
to	O
evaluate	O
comprehensively	O
diabetes	O
prevention	O
and	O
management	O
programs	I:C1303150
and	O
to	O
support	O
acquisition	O
of	O
evidence	O
that	O
could	O
influence	O
the	O
knowledge	O
translation	I:C3494164
of	O
innovations	O
to	O
reduce	O
the	O
burden	O
of	O
diabetes	O
.	O

Validated	O
by	O
experts	B:C0009817
,	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
has	O
the	O
right	O
theoretic	O
components	O
to	O
evaluate	O
comprehensively	O
diabetes	O
prevention	O
and	O
management	O
programs	I:C1303150
and	O
to	O
support	O
acquisition	O
of	O
evidence	O
that	O
could	O
influence	O
the	O
knowledge	O
translation	I:C3494164
of	O
innovations	O
to	O
reduce	O
the	O
burden	O
of	O
diabetes	O
.	O

Validated	O
by	O
experts	O
,	O
Diabetes	B:C0015194
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
has	O
the	O
right	O
theoretic	O
components	O
to	O
evaluate	O
comprehensively	O
diabetes	O
prevention	O
and	O
management	O
programs	I:C1303150
and	O
to	O
support	O
acquisition	O
of	O
evidence	O
that	O
could	O
influence	O
the	O
knowledge	O
translation	I:C3494164
of	O
innovations	O
to	O
reduce	O
the	O
burden	O
of	O
diabetes	O
.	O

Validated	O
by	O
experts	O
,	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
has	O
the	O
right	O
theoretic	O
components	O
to	O
evaluate	B:C0220825
comprehensively	O
diabetes	O
prevention	O
and	O
management	O
programs	I:C1303150
and	O
to	O
support	O
acquisition	O
of	O
evidence	O
that	O
could	O
influence	O
the	O
knowledge	O
translation	I:C3494164
of	O
innovations	O
to	O
reduce	O
the	O
burden	O
of	O
diabetes	O
.	O

Validated	O
by	O
experts	O
,	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
has	O
the	O
right	O
theoretic	O
components	O
to	O
evaluate	O
comprehensively	O
diabetes	O
prevention	O
and	O
management	B:C1303150
programs	I:C1303150
and	O
to	O
support	O
acquisition	O
of	O
evidence	O
that	O
could	O
influence	O
the	O
knowledge	O
translation	I:C3494164
of	O
innovations	O
to	O
reduce	O
the	O
burden	O
of	O
diabetes	O
.	O

Validated	O
by	O
experts	O
,	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
has	O
the	O
right	O
theoretic	O
components	O
to	O
evaluate	O
comprehensively	O
diabetes	O
prevention	O
and	O
management	O
programs	I:C1303150
and	O
to	O
support	O
acquisition	O
of	O
evidence	O
that	O
could	O
influence	O
the	O
knowledge	B:C3494164
translation	I:C3494164
of	O
innovations	O
to	O
reduce	O
the	O
burden	O
of	O
diabetes	O
.	O

Validated	O
by	O
experts	O
,	O
Diabetes	O
Evaluation	I:C0015194
Framework	I:C0015194
for	I:C0015194
Innovative	I:C0015194
National	I:C0015194
Evaluations	I:C0015194
has	O
the	O
right	O
theoretic	O
components	O
to	O
evaluate	O
comprehensively	O
diabetes	O
prevention	O
and	O
management	O
programs	I:C1303150
and	O
to	O
support	O
acquisition	O
of	O
evidence	O
that	O
could	O
influence	O
the	O
knowledge	O
translation	I:C3494164
of	O
innovations	O
to	O
reduce	O
the	O
burden	O
of	O
diabetes	B:C0011847
.	O

